LBTTFCLEVER CULTURE SYS LTD.

About CLEVER CULTURE SYS LTD. (LBTTF)

CLEVER CULTURE SYS LTD. (LBTTF) is a N/A company headquartered in Adelaide, SA, Australia whose shares trade over-the-counter on the Pink tier.

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds.

LBTTF key facts

Ticker symbol

LBTTF

Market tier

Pink

Headquarters

Adelaide, SA, Australia

Shares outstanding

329,874,450

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Pink stocks · OTC stocks starting with L